Hangbo Yang - Related publications

Zhejiang University, Hangzhou Shi, Zhejiang Sheng, China 
College of optical science and engineering
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Alfarsi LH, El Ansari R, Craze ML, Masisi BK, Ellis IO, Rakha EA, Green AR. PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer. Bmc Cancer. 20: 425. PMID 32410585 DOI: 10.1186/s12885-020-06939-6   
2020 Song X, Liang Y, Sang Y, Li Y, Zhang H, Chen B, Du L, Liu Y, Wang L, Zhao W, Ma T, Wang C, Yang Q. circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family. Molecular Therapy. Nucleic Acids. 20: 518-533. PMID 32330870 DOI: 10.1016/j.omtn.2020.03.014   
2020 Sun H, Zhou Y, Jiang H, Xu Y. Elucidation of Functional Roles of Sialic Acids in Cancer Migration. Frontiers in Oncology. 10: 401. PMID 32296639 DOI: 10.3389/fonc.2020.00401   
2020 Wang B, Zhang Y, Zhang H, Lin F, Tan Q, Qin Q, Bao W, Liu Y, Xie J, Zeng Q. Long intergenic non-protein coding RNA 324 prevents breast cancer progression by modulating miR-10b-5p. Aging. 12. PMID 32305959 DOI: 10.18632/aging.103021   
2020 Lee MM, Chan BD, Wong WY, Qu Z, Chan MS, Leung TW, Lin Y, Mok DK, Chen S, Tai WC. Anti-cancer Activity of Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-κB, and STAT3 Signaling Pathways. Frontiers in Oncology. 10: 491. PMID 32328465 DOI: 10.3389/fonc.2020.00491   
2020 Malouff TD, Mahajan A, Mutter RW, Krishnan S, Hoppe BS, Beltran C, Trifiletti DM, Vallow LA. Carbon ion radiation therapy in breast cancer: a new frontier. Breast Cancer Research and Treatment. 181: 291-296. PMID 32318954 DOI: 10.1007/s10549-020-05641-2   
2020 Chandimali N, Sun HN, Park YH, Kwon T. BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2. In Vivo (Athens, Greece). 34: 1085-1094. PMID 32354896 DOI: 10.21873/invivo.11879   
2020 Jiao XX, Lin SY, Lian SX, Qiu YR, Li ZH, Chen ZH, Lu WQ, Zhang Y, Deng L, Jiang Y, Hu GH. The inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway. Neoplasma. PMID 32386478 DOI: 10.4149/neo_2020_190805N716   
2020 Yang L, Liu B, Chen H, Gao R, Huang K, Guo Q, Li F, Chen W, He J. Progress in the application of organoids to breast cancer research. Journal of Cellular and Molecular Medicine. PMID 32283573 DOI: 10.1111/jcmm.15216   
2020 Lu Y, Zhao Y, Zhu Y, Xu X, Yin J. In situ research and diagnosis of breast cancer by using HOF-ATR-FTIR spectroscopy. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 235: 118178. PMID 32247254 DOI: 10.1016/j.saa.2020.118178   
2020 Zhao S, Li X, Yin L, Hou L, Lan J, Zhu X. TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF‑7 cells. Oncology Reports. PMID 32323833 DOI: 10.3892/or.2020.7577   
2020 Yuan C, Luo X, Zhan X, Zeng H, Duan S. EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis. International Journal of Molecular Medicine. PMID 32236616 DOI: 10.3892/ijmm.2020.4550   
2020 Devanathan N, Jones S, Kaur G, Kimble-Hill AC. Using Phosphatidylinositol Phosphorylation as Markers for Hyperglycemic Related Breast Cancer. International Journal of Molecular Sciences. 21. PMID 32230859 DOI: 10.3390/ijms21072320   
2020 Ortega MA, Fraile-Martínez O, Asúnsolo Á, Buján J, García-Honduvilla N, Coca S. Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR. Journal of Oncology. 2020: 9258396. PMID 32211045 DOI: 10.1155/2020/9258396   
2020 Zhang Y, Liu JL, Wang J. SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ. European Review For Medical and Pharmacological Sciences. 24: 3786-3794. PMID 32329855 DOI: 10.26355/eurrev_202004_20844   
2020 Ronchi A, Pagliuca F, Zito Marino F, Accardo M, Cozzolino I, Franco R. Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma. Seminars in Cancer Biology. PMID 32165319 DOI: 10.1016/j.semcancer.2020.03.002   
2020 Lu Y, Sha H, Sun X, Zhang Y, Wu Y, Zhang J, Zhang H, Wu J, Feng J. CRNDE: an oncogenic long non-coding RNA in cancers. Cancer Cell International. 20: 162. PMID 32435153 DOI: 10.1186/s12935-020-01246-3   
2020 To PK, Do MH, Cho JH, Jung C. Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics. International Journal of Molecular Sciences. 21. PMID 32340289 DOI: 10.3390/ijms21082991   
2020 Mansoori B, Duijf PHG, Mohammadi A, Najafi S, Roshani E, Shanehbandi D, Hajiasgharzadeh K, Shirjang S, Ditzel HJ, Kazemi T, Mokhtarzadeh A, Gjerstorff MF, Baradaran B. Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert Opinion On Therapeutic Targets. 1-11. PMID 32172636 DOI: 10.1080/14728222.2020.1736559   
2020 Anthis NJ, Kavanaugh-Lynch MHE. The Global Challenge to Prevent Breast Cancer: Surfacing New Ideas to Accelerate Prevention Research. International Journal of Environmental Research and Public Health. 17. PMID 32098181 DOI: 10.3390/ijerph17041394   
2020 Dattachoudhury S, Sharma R, Kumar A, Jaganathan BG. Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells. Oncology. 1-9. PMID 32434184 DOI: 10.1159/000505521   
2020 Atta Manu E, Bedu-Addo K, Titiloye NA, Ameh-Mensah C, Opoku F, Duduyemi BM. Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana. Journal of Oncology. 2020: 9752952. PMID 32377198 DOI: 10.1155/2020/9752952   
2020 Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, Safari E, Farahmand L. Breast cancer: Biology, biomarkers, and treatments. International Immunopharmacology. 84: 106535. PMID 32361569 DOI: 10.1016/j.intimp.2020.106535   
2020 Min HY, Pei H, Hyun SY, Boo HJ, Jang HJ, Cho J, Kim JH, Son J, Lee HY. Potent Anticancer Effect of the Natural Steroidal Saponin Gracillin Is Produced by Inhibiting Glycolysis and Oxidative Phosphorylation-Mediated Bioenergetics. Cancers. 12. PMID 32276500 DOI: 10.3390/cancers12040913   
2020 Jabbarzadeh Kaboli P, Salimian F, Aghapour S, Xiang S, Zhao Q, Li M, Wu X, Du F, Zhao Y, Shen J, Cho CH, Xiao Z. Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - A comprehensive review from chemotherapy to immunotherapy. Pharmacological Research. 104806. PMID 32294525 DOI: 10.1016/j.phrs.2020.104806   
2020 Xu T, Dong M, Li H, Zhang R, Li X. Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer. Oncology Letters. 19: 4053-4065. PMID 32391106 DOI: 10.3892/ol.2020.11533   
2020 Monje M, Borniger JC, D'Silva NJ, Deneen B, Dirks PB, Fattahi F, Frenette PS, Garzia L, Gutmann DH, Hanahan D, Hervey-Jumper SL, Hondermarck H, Hurov JB, Kepecs A, Knox SM, et al. Roadmap for the Emerging Field of Cancer Neuroscience. Cell. 181: 219-222. PMID 32302564 DOI: 10.1016/j.cell.2020.03.034   
2020 Wang L, Zhou S, Guo B. Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2. International Journal of Molecular Sciences. 21. PMID 32230936 DOI: 10.3390/ijms21072334   
2020 Zaheed O, Samson J, Dean K. A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset. Non-Coding Rna Research. 5: 48-59. PMID 32206740 DOI: 10.1016/j.ncrna.2020.02.004   
2020 Liu YL, Yan ZX, Xia Y, Xie XY, Zhou K, Xu LL, Shi YL, Wang Q, Bi JW. Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression. American Journal of Cancer Research. 10: 939-952. PMID 32266101   
2020 Sun X, Wang M, Wang M, Yu X, Guo J, Sun T, Li X, Yao L, Dong H, Xu Y. Metabolic Reprogramming in Triple-Negative Breast Cancer. Frontiers in Oncology. 10: 428. PMID 32296646 DOI: 10.3389/fonc.2020.00428   
2020 Zhuang S, Li L, Zang Y, Li G, Wang F. RRM2 elicits the metastatic potential of breast cancer cells by regulating cell invasion, migration and VEGF expression via the PI3K/AKT signaling. Oncology Letters. 19: 3349-3355. PMID 32256828 DOI: 10.3892/ol.2020.11428   
2020 Kim HM, Lee YK, Kim ES, Koo JS. Energy transfer from adipocytes to cancer cells in breast cancer. Neoplasma. PMID 32412774 DOI: 10.4149/neo_2020_191017N1050   
2020 Pan L, Chen X, Fu S, Yu W, Li C, Wang T, Lo HW, Lin J. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer. Breast Cancer Research and Treatment. PMID 32240456 DOI: 10.1007/s10549-020-05613-6   
2020 Alexander J, Cukierman E. Cancer Associated Fibroblast: Mediators of Tumorigenesis. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 32450219 DOI: 10.1016/j.matbio.2020.05.004   
2020 Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, Törnberg S, Chen SL, Chiu SY, Fann JC, Ku MM, Wu WY, Hsu CY, Chen YC, Svane G, et al. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. Cancer. PMID 32390151 DOI: 10.1002/cncr.32859   
2020 Fang K, Caixia H, Xiufen Z, Zijian G, Li L. Screening of a Novel Upregulated lncRNA, A2M-AS1, That Promotes Invasion and Migration and Signifies Poor Prognosis in Breast Cancer. Biomed Research International. 2020: 9747826. PMID 32352014 DOI: 10.1155/2020/9747826   
2020 Gu M, Zheng W, Zhang M, Dong X, Zhao Y, Wang S, Jiang H, Zheng X. LncRNA NONHSAT141924 promotes paclitaxel chemotherapy resistance through p-CREB/Bcl-2 apoptosis signaling pathway in breast cancer. Journal of Cancer. 11: 3645-3654. PMID 32284761 DOI: 10.7150/jca.39463   
2020 Qiu X, Wang Q, Song H, Shao D, Xue J. circ_103809 promotes breast cancer progression by regulating the PI3K/AKT signaling pathway. Oncology Letters. 19: 3725-3730. PMID 32382325 DOI: 10.3892/ol.2020.11507   
2020 Farrell K, Bennett DL, Schwartz TL. Screening for Breast Cancer: What You Need to Know. Missouri Medicine. 117: 133-135. PMID 32308238   
2020 Yang LF, Yang F, Zhang FL, Xie YF, Hu ZX, Huang SL, Shao ZM, Li DQ. Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis. Theranostics. 10: 5242-5258. PMID 32373210 DOI: 10.7150/thno.43744   
2020 Desai P, Thumma NJ, Wagh PR, Zhan S, Ann D, Wang J, Prabhu S. Cancer Chemoprevention Using Nanotechnology-Based Approaches. Frontiers in Pharmacology. 11: 323. PMID 32317961 DOI: 10.3389/fphar.2020.00323   
2020 Brown JM, Wasson MD, Marcato P. The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs. Cells. 9. PMID 32244924 DOI: 10.3390/cells9030763   
2020 Sun L, Shi C, Liu S, Zhang E, Yan L, Ji C, Zhao Y. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis. Gene. 144657. PMID 32298762 DOI: 10.1016/j.gene.2020.144657   
2020 Li XF, Aierken AL, Shen L. IPO5 promotes malignant progression of esophageal cancer through activating MMP7. European Review For Medical and Pharmacological Sciences. 24: 4246-4254. PMID 32373960 DOI: 10.26355/eurrev_202004_21004   
2020 Xu G, Ye D, Zhao Q, He R, Ma W, Li Y, Tang S, Zhou Z, Li X, Zhang Z. circNFIC suppresses breast cancer progression by sponging miR-658. Journal of Cancer. 11: 4222-4229. PMID 32368305 DOI: 10.7150/jca.38830   
2020 Sharma U, Barwal TS, Acharya V, Tamang S, Vasquez KM, Jain A. Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment. Translational Oncology. 13: 100774. PMID 32450549 DOI: 10.1016/j.tranon.2020.100774   
2020 Ohayon JL, Nost E, Silk K, Rakoff M, Brody JG. Barriers and opportunities for breast cancer organizations to focus on environmental health and disease prevention: a mixed-methods approach using website analyses, interviews, and focus groups. Environmental Health : a Global Access Science Source. 19: 15. PMID 32041648 DOI: 10.1186/s12940-020-0570-7   
2020 Ahmed S, Pati S, Le D, Haider K, Iqbal N. The prognostic and predictive role of 21-gene recurrence scores in hormone receptor-positive early-stage breast cancer. Journal of Surgical Oncology. PMID 32346902 DOI: 10.1002/jso.25952   
2020 Dang Cong T, Nguyen Thanh T, Nguyen Phan QA, Hoang Thi AP, Nguyen Tran BS, Nguyen Vu QH. Correlation between HER2 Expression and Clinicopathological Features of Breast Cancer: A Cross- Sectional Study in Vietnam. Asian Pacific Journal of Cancer Prevention : Apjcp. 21: 1135-1142. PMID 32334482 DOI: 10.31557/APJCP.2020.21.4.1135